Enjoy complimentary customisation on priority with our Enterprise License!
The global vaccines market size is estimated to grow by USD 56.39 billion, at a CAGR of 13.83% between 2023 and 2028. Global population health has recently improved due to enhanced public health measures, science-based medicine, and vaccine developments. Strong research and development, often through public-private partnerships, have eradicated serious infectious diseases. Manufacturers now heavily invest in technical capabilities for vaccine life cycle management, necessitating collective efforts from manufacturers, regulators, and suppliers. Such partnerships, involving governments, researchers, purchasers, and policymakers, drive vaccine innovation success. Increased funding has led to numerous vaccine candidates in various clinical trial stages. The wave in investments and the launch of vaccines for diverse infectious diseases are set to fuel the market's growth in the forecast period.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.